Literature DB >> 9879449

Spatial heterogeneity of myocardial perfusion and metabolism.

U K Decking1, J Schrader.   

Abstract

Left ventricular myocardium is characterized by a substantial spatial heterogeneity of both perfusion and metabolism. Under resting conditions, the transmural gradient of myocardial oxygen consumption (MVO2) from the subepi- to the subendocardial layer exceeds that of coronary flow, resulting in a lower subendocardial PO2, altered kinetics of oxidative phosphorylation, and enhanced free cytosolic adenosine. Within each layer, there is a major spatial variability of perfusion: Local flow rates in individual myocardial samples (200 mg) range from 20-250% of the mean myocardial blood flow. Low flow areas (< 50% of mean flow) display a rather low uptake of fatty acids and glucose; the uptake of these substrates increases in proportion to local flow. There is also a close relationship between local perfusion and the local turnover of the tricarboxylic acid cycle and, thus, MVO2 as was recently demonstrated using 13C NMR techniques. Consequently, within the well perfused left ventricular myocardium local MVO2 and, thus, energy turnover varies more than 3-fold between low and high flow areas. Low flow areas are not ischemic, since local lactate, adenosine, and ATP are comparable to mean flow areas. When coronary perfusion pressure is reduced, the transmural perfusion gradient reverses resulting in impaired energy status and enhanced adenosine predominantly in the subendocardium. This rise in local adenosine or lactate requires a decrease of the individual local flow by more than 50% of its preischemic value. It, thus, appears that not the absolute level of local flow predicts the impact of ischemia but its relative change.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9879449     DOI: 10.1007/s003950050113

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  7 in total

Review 1.  Heterogeneity of myocardial blood flow and metabolism: review of physiologic principles and implications for radionuclide imaging of the heart.

Authors:  Henry Gewirtz; Ahmed Tawakol; Stephen L Bacharach
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

2.  Effects of hypoxia on coronary microcirculation during postnatal development.

Authors:  Fumio Yamamoto; Hiroshi Yamamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-10-08

Review 3.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

4.  Optical Cryoimaging Reveals a Heterogeneous Distribution of Mitochondrial Redox State in ex vivo Guinea Pig Hearts and Its Alteration During Ischemia and Reperfusion.

Authors:  Mahsa Ranji; Mohammad Masoudi Motlagh; Fahimeh Salehpour; Reyhaneh Sepehr; James S Heisner; Ranjan K Dash; Amadou K S Camara
Journal:  IEEE J Transl Eng Health Med       Date:  2016-06-15       Impact factor: 3.316

5.  Enhancement of Gap Junction Function During Acute Myocardial Infarction Modifies Healing and Reduces Late Ventricular Arrhythmia Susceptibility.

Authors:  Fu Siong Ng; Jeremy M Kalindjian; Simon A Cooper; Rasheda A Chowdhury; Pravina M Patel; Emmanuel Dupont; Alexander R Lyon; Nicholas S Peters
Journal:  JACC Clin Electrophysiol       Date:  2016-10

Review 6.  Ivabradine, coronary artery disease, and heart failure: beyond rhythm control.

Authors:  Pietro Scicchitano; Francesca Cortese; Gabriella Ricci; Santa Carbonara; Michele Moncelli; Massimo Iacoviello; Annagrazia Cecere; Michele Gesualdo; Annapaola Zito; Pasquale Caldarola; Domenico Scrutinio; Rocco Lagioia; Graziano Riccioni; Marco Matteo Ciccone
Journal:  Drug Des Devel Ther       Date:  2014-06-03       Impact factor: 4.162

7.  3D IMAGING OF THE MITOCHONDRIAL REDOX STATE OF RAT HEARTS UNDER NORMAL AND FASTING CONDITIONS.

Authors:  He N Xu; Rong Zhou; Lily Moon; Min Feng; Lin Z Li
Journal:  J Innov Opt Health Sci       Date:  2014-03-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.